Endothelial dysfunction in children with chronic kidney disease

Juan Antonio García-Bello1, Rita A Gómez-Díaz2, Alicia Contreras-Rodríguez3

  • 1División de Investigación, Unidad Médica de Alta Especialidad Hospital de Gineco Obstetricia No. 3, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.

Nefrologia
|September 27, 2022
PubMed

Insights

Cardiovascular disease risk factors like high triglycerides, inflammation, and low intact parathyroid hormone (iPTH) are linked to endothelial dysfunction in children with chronic kidney disease (CKD). These factors are common and treatable, offering potential interventions for CVD prevention.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Research
  • Inflammation and Immunology

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality in pediatric patients with chronic kidney disease (CKD).
  • Inflammation and endothelial dysfunction (ED) are prevalent in these children and are significant contributors to CVD.
  • Flow-mediated dilation (FMD) is a validated surrogate marker for assessing ED.

Purpose of the Study:

  • To identify risk factors associated with endothelial dysfunction (ED) in children suffering from chronic kidney disease (CKD).
  • To investigate the relationship between biochemical markers, inflammation, and ED in pediatric CKD patients.

Main Methods:

  • A cohort of 129 children aged 2-16 years with CKD was studied.
  • Clinical data and biochemical variables, including intact parathyroid hormone (iPTH), hsCRP, and triglycerides, were collected.
  • Endothelial dysfunction was assessed using flow-mediated dilation (FMD), with FMD < 7% considered abnormal.

Main Results:

  • Over half (52.7%) of the children exhibited altered FMD (< 7%).
  • Patients with abnormal FMD showed significantly higher levels of triglycerides and high-sensitivity C-reactive protein (hsCRP) compared to those with normal FMD.
  • Low iPTH levels were more frequent in children with altered FMD, and both low iPTH and elevated hsCRP were independently associated with an increased risk of ED.

Conclusions:

  • Hypertriglyceridemia, inflammation (indicated by hsCRP), and low intact parathyroid hormone (iPTH) are significantly associated with endothelial dysfunction in children with CKD.
  • These identified factors represent frequent and treatable risk factors for cardiovascular disease (CVD) in this vulnerable pediatric population.
  • Targeting these modifiable risk factors may help mitigate the progression of CVD in children with chronic kidney disease.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
59
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
64
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
71
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
58
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
45
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
3.3K